Transcript: Kirsten Gillibrand on "Face the Nation"
The following is a transcript of an interview with New York Senator Kirsten Gillibrand that aired Sunday, November 21, 2021, on "Face the Nation."
Watch CBS News
The following is a transcript of an interview with New York Senator Kirsten Gillibrand that aired Sunday, November 21, 2021, on "Face the Nation."
The president is also facing criticism on his handling of immigration.
In this weekend's edition of "London Calling," CBS News contributor Simon Bates discusses the COVID-19 crisis as cases surge across Europe. In his opinion, the rising number of hospitalizations and infections may still fail to deter families from uniting this holiday season.
U.S. health officials authorized the Pfizer, Moderna and Johnson and Johnson COVID-19 booster shots for all adults. Justin Lowenthal of Doctors for America joins CBSN's Lana Zak to discuss more.
Millions of Americans are now eligible for COVID-19 booster shots after the Centers for Disease Control and Prevention expanded eligibility for shots to all adults. It comes as the average number of COVID cases in the nation is up 24% since November 4. Elise Preston has the story.
The CDC has signed off on COVID-19 booster shots for all adults. Those 18 and older can now get an additional dose of either the Pfizer or Moderna vaccine. David Begnaud has more.
Federal health officials are endorsing both Pfizer and Moderna vaccine boosters for anyone over the age of 18 as COVID-19 cases surge in new hotspots around the U.S. Dr. Lauren Hughes, an associate professor of family medicine at the University of Colorado, shares the details with CBSN anchor Lana Zak.
Researchers found that pregnant women with COVID-19 had higher rates of ICU admission, death and stillbirths.
The CDC is expected to recommend all U.S. adults should have access to COVID-19 vaccine booster shots. CBS News researcher and reporter Max Bayer spoke with CBSN's Tanya Rivero about what officials are considering.
The FDA has now authorized Moderna's and Pfizer's COVID-19 vaccine booster shots for all adults. Dr. Bob Lahita, director of the Institute for Autoimmune and Rheumatic Diseases at St. Joseph Health and author of the forthcoming book "Immunity Strong," joins CBSN to discuss the latest on the pandemic and vaccines.
Moderna has formally requested the FDA authorize expansion of its COVID-19 booster shot to all adults. Federal health officials are expected to authorize expansion of Pfizer's booster this week. It comes as cases continue to rise across the U.S. Emergency medicine physician Dr. Owais Durrani joins CBSN's Lana Zak to discuss.
For the first time ever, more than 100,000 Americans died of drug overdoses in one year. Manuel Bojorquez takes a look at what's fueling the surge.
The Food and Drug Administration moved to expand its emergency authorization of Pfizer's and Moderna's COVID-19 vaccine booster shots to all adults on Friday.
The lockdown will last up to 20 days, and the vaccination requirement for adults starts in February, as much of Europe tries to fend off another wave of coronavirus infections.
"I have never seen so many people on a ventilator at one time," one doctor said.
Virologist Michael Worobey was among those who pushed for consideration of a lab leak, but he says further analysis makes that origin theory "very difficult to explain."
COVID-19 cases are on the rise in the U.S. ahead of the holidays. Emergency medicine physician Dr. Hilary Fairbrother joins CBSN's Lana Zak for more.
Minnesota is seeing a surge in COVID-19 cases and hospitalizations among the unvaccinated. WCCO's Liz Collin has more.
The federal agency said it is complying with a court ruling that temporarily halts the regulation for big employers.
A variant of the Delta virus that is more infectious, but is less likely to cause symptoms, now accounts for more than 1 in 10 COVID-19 cases in England, while the head of the Women's Tennis Association casts doubt on an email attributed to missing Chinese tennis player Peng Shuai. Ian Lee reports for CBSN AM from London on these and other stories from around the world.
The Food and Drug Administration could authorize the Pfizer booster shot for all adults as early as Thursday. Infectious disease specialist Dr. Amesh Adalja joins CBSN to discuss how expanding booster shot eligibility will effect the country's fight against COVID-19.
Parts of Europe are seeing a wave of COVID-19 infections as colder weather sets in, forcing some countries to implement new social restrictions and partial lockdowns. CBS News foreign correspondent Imtiaz Tyab reports on the current surge for CBSN.
The Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine booster shot for all adults in the U.S. as soon as this week. Pfizer is also seeking emergency-use authorization for its COVID antiviral pill. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
The FDA and CDC could expand eligibility of the Pfizer booster shot as early as this week. The drugmaker is also seeking emergency use authorization for its COVID-19 antiviral pill, Paxlovid. CBS News' Naomi Ruchim reports, and then Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, joins CBSN's Tanya Rivero to discuss the latest progress in the fight against the coronavirus pandemic.
With kids now eligible to get the vaccine, some families are struggling to decide whether or not to get their kids vaccinated. Lead national correspondent David Begnaud spoke to one Louisiana family who made the decision to be first in line after a complicated journey to getting the vaccine.